WASHINGTON—New Heritage Foundation research shows that access to puberty blockers and cross-sex hormones does not reduce youth suicide rates. This challenges a key argument that such access to gender transition drugs saves lives.
Jay Greene, a senior research fellow at the conservative think tank’s center for education policy, authored a report on the findings, hoping the new evidence would allow policymakers to take more cautious and deliberate approaches to set regulations.